Cancer stem cells (CSCs) have recently gained major importance as novel targets in targeted cancer therapy and quercetin research is further supported by its inherent capacity to inhibit CSCs through the PI3K/Akt and MAPK/ERK pathways in prostate CSCs [130] and the PI3K/Akt/mTOR signaling pathways in breast CSCs [131]. This evidence concerns the gene MTOR and cancer.